Is phase 3 data not even enough?? As mentioned, the world

New Post Public Reply Private Reply Replies (4) Message Board
Lee Ron Lemab viridi #63239
722
Is phase 3 data not even enough?? As mentioned, the world is in crisis and the SOC for this pandemic is remdesivir (which is basically placebo+ assult on your liver, already perhaps being assulted by the cytokine storm) and dexamethasone (which is great for reducing inflammation and no doubt saving some lives).

When millions of people are dying around the world, treatments that work/save lives must be expiteded - especially treatments that have proven to have a better safety profile than SOC and have an MOA that reduces viral load and calms the cytokine storm that ravages organs.

This drug is tested in over 1000 people proving safety (no side effects) and phase 3 of CD12 would prove more efficacy in addition to CD10 data. Is that really not enough for an EUA? Remdesivir got an EUA and it is bad for the liver, an organ with over 300+ important metabolic functions. With that, it became the SOC and got full approval. It's not proven to be any better than placebo in saving lives and even apsirin is proving to save lives for covid patients - https://www.sciencedaily.com/releases/2020/10...195637.htm .

Saving lives is what this world needs and if phase 3 proves Leronlimab saves lives for covid patients than why the need for phase 4?

If CD12 data proves efficacy at next interim analysis (on mortality, one of the hardest primary endpoint to achieve), why would more testing be needed? Especially if people are dying by the 100s of thousands with current SOC.

Starting to feel like I'm being given a path of small bread crumbs with stories of a great meal at the end of them, provided I find and eat each one.

I can already imagine a CC at the end of the next interim analysis or even in completion of a successful phase 3 "We got the best news we could have possibly received (other than getting EUA), and we excited to do a phase 4 with 700 patients. We know we will get them quicker now that the remdesivir trials are over and look fowrard to providing the FDA what they want for the EUA."

I understand in normal times trials are 4 full phases, but this is more than a rush to improve SOC and safe countless lives for an out of control pandemic!!

If this system is THIS dysfunctional I'd like to know. It's getting worse the more I learn. Please reply if you have insights about the need for a phase 4 if phase 3 shows safety and efficacy (including hitting stastical sign. on primary endpoint - mortality.

Thanks
1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

RxWellness Hits Inc. 5000—Four Straight Wins Impress

Updated Category News Views 6

RxWellness Spine & Health Continues to Impress Well, not many companies can boast about snagging a spot on the Inc. 5000 list four years in a row, but here we are with RxWellness Spine & Health doing just that. Sitting pretty at No. 1,230 nationally—and that's no small feat—these folks are making waves in the healthcare industry. Securing the No. 135 spot in...

Continue Reading
G-STAR & Wu-Tang Clan Unleash Denim Fusion

Updated Category News Views 5

Denim and Old-School Beats: A Fresh Partnership Just when you think fashion collaborations have run their course, along comes something worth the buzz. This fall, G-STAR, the edgy Dutch denim frontrunner, and the legendary hip-hop collective of Wu-Tang Clan are shaking up the apparel scene, blending raw denim with raw rap. It's a multi-year collaboration that doesn't slap...

Continue Reading
Alcott HR's Sales Strategy Gets a Boost with New Hire

Updated Category News Views 9

Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...

Continue Reading
Paula's Choice Elevates Skincare Game with New Campaign

Updated Category News Views 5

Strategy Meets Skincare: Paula's Choice in the Spotlight Catch this: Paula's Choice just dropped a moisturizer, but it ain't just lotion. No, the Pro-Collagen Peptide Plumping Intensive Moisturizer is here with a punch. And they've got Hannah Waddingham, of 'Ted Lasso' fame, fronting a campaign that screams confidence. Now, that's a way to announce your move at the...

Continue Reading
Citrine Finalizes Sale of Illinois Senior Living Asset

Updated Category News Views 6

Citrine's Strategic Exit from River Glen Every now and then, you see a company pull off something that makes you nod and say, "That was smart." Citrine Investment Group's sale of River Glen of St. Charles fits that bill. For those keeping tabs, this wasn't some quick flip—Citrine worked on the rock for a good while before cashing in. They secured River Glen back in...

Continue Reading
CSS Revamps Identity, Emphasizing Senior Living Tech

Updated Category News Views 4

CSS Takes a Bold Step with a Fresh Brand Identity Every now and then, you see a company shake off the old coat and put on a polished new one. That's what CSS is doing with its updated brand, staking its claim as a heavyweight tech player in the senior living sector. No small feat, given the challenges stacked against these aging communities—tasked with keeping...

Continue Reading
Feeding Families Foundation Gains $121,500 for NYC Push

Updated Category News Views 4

Holy smokes, here comes some good news in the nonprofit corners! Feeding Families Foundation just got a hefty $121,500 boost from the Association of Contracting Plumbers of the City of New York Inc. This ain't just some pocket change; it's a full-fledged lifeline that helps them keep on delivering meals to parents who are practically living at their kid’s hospital...

Continue Reading
NOAA Taps ICEYE US for Game-Changing SAR Satellite Data

Updated Category News Views 6

The Strategic Move to SAR Data Imagine this: You’re in the thick of a hurricane, where visibility goes out the window, and traditional satellite data chokes under the crushing weight of clouds and nightfall. That's the precise chaos ICEYE US is cutting through with its Synthetic Aperture Radar (SAR) technology. The latest scuttlebutt is that NOAA's getting cozy with...

Continue Reading
Robotics in Cleaning: 2026 Sees Double Adoption Rates

Updated Category News Views 4

Cleaning Industry Eyes Robotic Solutions Amid Labor Squeeze In a twist that's got industry veterans nodding knowingly, the cleaning industry is tipping towards automation. The recent 2026 Building Service Contractor Market Study reveals a massive leap: 32% of building service contractors (BSCs) plan to embrace robotic floor equipment in the coming year. That's a...

Continue Reading
TWP & Commbi Unveil Exclusive Pony Clog Collaboration

Updated Category News Views 5

A Fusion of Fashion and Functionality Walk down the streets of New York or hustle your way through an airport without worrying about your footwear weighing you down. That's the promise coming from the fresh alliance between TWP and Commbi with their new Pony Clog Collaboration. A blend of high fashion and everyday utility, these clogs aren't just keeping up with the...

Continue Reading

Top 5 Most Recently Viewed Articles

Gold Prices React to Tariff Announcements and Global Tensions

Updated Category News Views 299

Gold Prices Decline Amid Tariff Announcement The price of gold has faced a notable decline, representing the largest drop in three months. This shift comes as the U.S. government aims to clarify its tariff plans concerning bullion imports. Understanding the Tariff Impact On the latest trading day, the front-month gold futures contract on the NYMEX exchange fell by 2.1%,...

Continue Reading
Candel Therapeutics Announces Participation in Key Investor Events

Updated Category News Views 96

Engagement in Investor Conferences Candel Therapeutics, Inc. (NASDAQ: CADL) has recently announced its participation in important investor conferences where its President and CEO, Paul Peter Tak, will be engaging with potential and current investors. This provides a significant opportunity for stakeholders to gain insights into the company’s innovative approach to...

Continue Reading
Federated Hermes Details Earnings Call for Q3 2025 Results

Updated Category News Views 138

Federated Hermes Earnings Announcement for Q3 2025 Federated Hermes, Inc. (NYSE: FHI), a leader in global active investment management, is preparing to share its financial results for the quarter ending September 30, 2025. The announcement will take place following market closure on Thursday, October 30, 2025. This timely report is crucial for stakeholders and potential...

Continue Reading
Barry Adcock Joins Quantalytix to Enhance Sales Strategy

Updated Category News Views 214

Quantalytix grabbed headlines when they brought in Barry Adcock as their new Sales Executive to tighten the screws on banking performance and risk management. You remember those days when banks were floundering—Adcock's the guy who's been through it all, from being CFO to navigating through the mud of economic downturns. Adcock's Banking Mastery: Navigating Challenges...

Continue Reading
Key Highlights of Man Group PLC's Public Disclosure on Spirent

Updated Category News Views 118

Understanding Man Group PLC's Disclosure Man Group PLC is a prominent player in the financial services sector, known for its investment management solutions. As part of regulatory compliance, the company has recently announced its public opening position disclosure regarding its interests in Spirent Communications plc. This disclosure not only reflects Man Group's...

Continue Reading